{
    "clinical_study": {
        "@rank": "102741", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.   Identify latent hypoparathyroidism in normocalcemic adult survivors with\n      repaired conotruncal cardiac defects, by evaluating parathyroid gland secretory function\n      after induced hypocalcemia.\n\n      II.  Determine the relationship of parathyroid hormone secretion to microdeletions in the\n      same region of chromosome 22q11 as found in patients with DiGeorge anomaly."
        }, 
        "brief_title": "Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects", 
        "condition": [
            "Hypoparathyroidism", 
            "Tetralogy of Fallot", 
            "Pulmonary Valve Stenosis", 
            "Conotruncal Cardiac Defects", 
            "Heart Defects, Congenital", 
            "Pulmonary Atresia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Constriction, Pathologic", 
                "Heart Defects, Congenital", 
                "Hypoparathyroidism", 
                "Pulmonary Valve Stenosis", 
                "Tetralogy of Fallot", 
                "Pulmonary Atresia"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients are given sodium citrate over a 2 hour infusion on day 1.  Blood is drawn at times\n      -30, -15, 0, and every 10 minutes thereafter during the infusion.  On day 2, patients are\n      given calcium gluconate over a 2 hour infusion.  Blood is drawn at times -30, -15, 0, and\n      every 10 minutes thereafter during the infusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Diagnostically shown repaired or palliated conotruncal cardiac defects, including\n             tetralogy of Fallot with pulmonary stenosis or pulmonary atresia, truncus arteriosus,\n             or interrupted aortic arch type B"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "150", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004361", 
            "org_study_id": "199/11936", 
            "secondary_id": "NU-553"
        }, 
        "intervention": [
            {
                "intervention_name": "calcium gluconate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "sodium citrate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Citric Acid"
        }, 
        "keyword": [
            "DiGeorge syndrome", 
            "cardiovascular and respiratory diseases", 
            "conotruncal cardiac defects", 
            "endocrine disorders", 
            "genetic diseases and dysmorphic syndromes", 
            "hypoparathyroidism", 
            "pulmonary valve stenosis", 
            "rare disease", 
            "tetralogy of Fallot"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Ann & Robert H Lurie Children's Hospital of Chicago", 
            "last_name": "Craig B. Langman", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004361"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Ann & Robert H Lurie Children's Hospital of Chicago", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 1995", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "January 2001"
    }, 
    "geocoordinates": {}
}